Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs Article

Roseberry, K, Le-Niculescu, H, Levey, DF et al. (2023). Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs . MOLECULAR PSYCHIATRY, 28(7), 2894-2912. 10.1038/s41380-023-01998-0

cited authors

  • Roseberry, K; Le-Niculescu, H; Levey, DF; Bhagar, R; Soe, K; Rogers, J; Palkowitz, S; Pina, N; Anastasiadis, WA; Gill, SS; Kurian, SM; Shekhar, A; Niculescu, AB

authors

publication date

  • July 1, 2023

published in

keywords

  • BIOMARKERS
  • Biochemistry & Molecular Biology
  • GENES
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • Psychiatry
  • SUICIDALITY
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGERNATURE

start page

  • 2894

end page

  • 2912

volume

  • 28

issue

  • 7